Febuxostat for Tumor Lysis Syndrome Prevention in Hematological Malignancies of Paediatric Patients and Adults
Status:
Terminated
Trial end date:
2018-07-25
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the exposure of febuxostat in pediatric patients
(≥6<18 years of age) and in adults suffering from hematological malignancies at intermediate
to high risk of TLS and to compare the effect in terms of serum uric acid levels.